Drug General Information
Drug ID	D0H2AM
Former ID	DIB011094
Drug Name	XR-3054
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Terminated	[525621]
Company	Xenova Group plc
Structure		Download 2D MOL 3D MOL
Canonical SMILES	C1(O[C@@]2(CO1)CC[C@@H](C(=C)C)CC2)(C)C
CAS Number	CAS 247090-97-7
Target and Pathway
Target(s)	Protein farnesyltransferase beta subunit	Target Info	Inhibitor	[525621]
KEGG Pathway	Terpenoid backbone biosynthesis
	Biosynthesis of antibiotics
NetPath Pathway	TSH Signaling Pathway
Reactome	Inactivation, recovery and regulation of the phototransduction cascade
WikiPathways	Visual phototransduction
References
Ref 525621	XR3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase. Eur J Cancer. 1999 Jun;35(6):1014-9.
Ref 525621	XR3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase. Eur J Cancer. 1999 Jun;35(6):1014-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.